Molecular characterization of breast cancer cell response to metabolic drugs

Metabolic reprogramming is a hallmark of cancer. It has been described that breast cancer subtypes present metabolism differences and this fact enables the possibility of using metabolic inhibitors as targeted drugs in specific scenarios. In this study, breast cancer cell lines were treated with met...

Descripción completa

Detalles Bibliográficos
Autores principales: Trilla-Fuertes, Lucía, Gámez-Pozo, Angelo, Arevalillo, Jorge M., Díaz-Almirón, Mariana, Prado-Vázquez, Guillermo, Zapater-Moros, Andrea, Navarro, Hilario, Aras-López, Rosa, Dapía, Irene, López-Vacas, Rocío, Nanni, Paolo, Llorente-Armijo, Sara, Arias, Pedro, Borobia, Alberto M., Maín, Paloma, Feliú, Jaime, Espinosa, Enrique, Fresno Vara, Juan Ángel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2018
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5839391/
https://www.ncbi.nlm.nih.gov/pubmed/29515760
http://dx.doi.org/10.18632/oncotarget.24047

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5839391/
https://www.ncbi.nlm.nih.gov/pubmed/29515760
http://dx.doi.org/10.18632/oncotarget.24047

Ejemplares similares